<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha in <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> has been studied in 59 patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, 28 with android type <z:hpo ids='HP_0001513'>obesity</z:hpo> and 35 healthy lean controls </plain></SENT>
<SENT sid="1" pm="."><plain>Immunoreactive concentrations and bioactivity of serum <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha have repeatedly been determined in 8 weeks intervals for 12 months, five times per patients, by using ELISA and L929 cell cytotoxicity bioassay </plain></SENT>
<SENT sid="2" pm="."><plain>Significantly higher immunoreactive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha concentrations and bioactivity have been found in both, the Type 2 diabetic and <z:mp ids='MP_0001261'>obese</z:mp> groups as compared to the healthy persons </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha concentrations and bioactivity have showed a significant positive linear correlation with the elevated basal serum C-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels and body mass indexes in both groups of patients </plain></SENT>
<SENT sid="4" pm="."><plain>According to these data the cytokine might play a role in <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in <z:hpo ids='HP_0001513'>obesity</z:hpo> as well in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>